Clinical Trial Update: Safety Study of Human Anti-Cytomegalovirus Monoclonal Antibody [Phase 1]

View source ↗

Summary

A Phase 1 safety study of a human anti-Cytomegalovirus monoclonal antibody sponsored by Theraclone Sciences has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infections

Drugs mentioned

• Human Anti-Cytomegalovirus Monoclonal Antibody

Snippet

Sponsor: Theraclone Sciences, Inc. | Conditions: Cytomegalovirus Infections | Phase 1 | Status: COMPLETED